Interstitial Keratitis with Lipid Keratopathy Mimicking Corneal Opacity Induced by Brimonidine Tartrate Eye Drops

Klin Monbl Augenheilkd 2020; 237(12): 1466-1467
DOI: 10.1055/a-1265-7105

Der interessante Fall

Interstitielle Keratitis mit Lipidkeratopathie ähnlich wie Hornhauttrübung mit Nebenwirkungen von Brimonidine-tartrate-Augentropfen

Yuka Kasuya

Ophthalmology, Jichi Medical University, Shimotsuke, Japan

,

Ichiya Sano

Ophthalmology, Jichi Medical University, Shimotsuke, Japan

,

Shinji Makino

Ophthalmology, Jichi Medical University, Shimotsuke, Japan

References
1 Alfonso E, Arrellanes L, Boruchoff SA. et al. Idiopathic bilateral lipid keratopathy. Br J Ophthalmol 1988; 72: 338-343
2 Barchiesi BJ, Eckel RH, Ellis PP. The cornea and disorders of lipid metabolism. Surv Ophthalmol 1991; 36: 1-22
3 Sharif Z, Sharif W. Corneal neovascularization: updates on pathophysiology, investigations & management. Rom J Ophthalmol 2019; 63: 15-22
4 Chu HS, Hu FR, Yang CM. et al. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition. Cornea 2011; 30: 60-66
5 Pang Y, Zhang Q, Bao Y. A CARE-compliant article: ipsilateral progressive idiopathic lipid keratopathy: A case report. Medicine (Baltimore) 2019; 98: e16589
6 Maruyama Y, Ikeda Y, Yokoi N. et al. Severe corneal disorders developed after brimonidine tartrate ophthalmic solution use. Cornea 2017; 36: 1567-1569
7 Tsujinaka A, Takai Y, Inoue Y. et al. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution. Acta Ophthalmol 2019; 97: e948-e949
8 Manabe Y, Sawada A, Mochizuki K. Corneal sterile infiltration induced by topical use of ocular hypotensive agent. Eur J Ophthalmol 2019;
9 Yorifuji A, Hosotani Y, Okamoto M. et al. Three cases of corneal disorders developed after brimonidine tartrate ophthalmic solution use. Ganka 2019; 61: 1527-1533